ProPedix
Boston, US · Founded 2024 · Delaware corporation
Propedix is a biopharma and consumer health company developing topical treatments for dermatological conditions and skin infections, such as athlete's foot and other fungal conditions. Its first product, Dryello, is a dermatologist-developed topical treatment for athlete's foot backed by clinical research.
Founders & leadership
ProPedix was founded in 2024 by Carl Schanbacher.
CS
Carl SchanbacherinFounder & CMO
Reported raises · per SEC filings
Form D private placements$800K disclosed across 1 round · 2024
▶$800KraisedNov 2024 · 5 investors · Other Health CareRule 506(b)
▶$800KraisedNov 2024 · 5 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Carl SchanbacherExecutive Officer, Director
- Offering amount
- $1M
- Amount sold
- $800K
- Minimum investment
- $100K
- First sale
- Nov 2024
- Incorporated
- Corporation, Delaware, 2024
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- What does ProPedix do?
- Propedix is a biopharma and consumer health company developing topical treatments for dermatological conditions and skin infections, such as athlete's foot and other fungal conditions. Its first product, Dryello, is a dermatologist-developed topical treatment for athlete's foot backed by clinical research.
- Who founded ProPedix?
- ProPedix was founded by Carl Schanbacher in 2024.
- How much funding has ProPedix raised?
- ProPedix has disclosed $800K raised across 1 round.
- Where is ProPedix headquartered?
- ProPedix is headquartered in Boston, US.